IMPACT STATEMENT.
The unprecedented pandemic by COVID-19 lead to a special attention to
vulnerability of children. Clinical and experimental studies suggest a
link between allergy and viral acute RS, whereas any correlation may be
established with bacterial acute RS. Anti-allergy treatment may prevent
and reduce severity of viral acute RS even though any articles
investigated specifically the link between allergy and upper airway
involvement by the new coronavirus in children. Nevertheless, in this
particular era a regular treatment plan should be adopted in allergic
children not only to reduce the risk of viral acute RS but also because
symptoms may considerably overlap. Finally, although there is no proof
of causation of allergy in chronic RS children, anti-allergy treatment
might improve outcomes of its specific treatment.